RecruitingNot ApplicableNCT07291154

Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

Sponsor

Yunfeng Xia

Enrollment

392 participants

Start Date

Sep 22, 2025

Study Type

INTERVENTIONAL

Conditions

End Stage Renal Disease (ESRD)Maintenance Hemodialysis

Summary

Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes. This trial aims to evaluate whether management through the "Yueya" mini-program and WeChat can provide personalized guidance such as health education, diet, exercise, medication supervision, and condition monitoring to enhance treatment compliance, quality of life, strengthen quality control in the hemodialysis unit, and improve patient prognosis. Patients will be divided into a group receiving support via the "Yueya" mini-program and WeChat, and a control group receiving routine care. Clinical and laboratory indicators, cardiovascular events, death, hospitalization, quality of life, and compliance will be recorded and compared between groups to assess the impact of APP-assisted patient management on the quality of MHD blood purification therapy and the prognosis of MHD patients.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a smartphone app ("Yueya" mini-program on WeChat) can help kidney dialysis patients better manage their treatment quality and health monitoring between dialysis sessions. **You may be eligible if...** - You have stage 5 chronic kidney disease and have been on maintenance hemodialysis (kidney dialysis) for more than 3 months - You attend dialysis three times a week - You are between 18 and 75 years old - Your condition is relatively stable and you can take care of yourself - You can use WeChat and the Yueya mini-program **You may NOT be eligible if...** - You have difficulty communicating or cooperating with the study - You have had a heart attack, stroke, or brain bleed in the past 6 months - You are unwilling to actively participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAPP-based management

Based on patients' specific conditions such as age, gender, primary disease, and complications, the APP-based management will provide individualized and round-the-clock guidance for dialysis patients in their daily lives through the "Yueya" mini-program and WeChat. This guidance covers various aspects, including health knowledge education, diet and exercise guidance, medication supervision, condition monitoring, and real-time feedback.